celastrol has been researched along with Dermatitis, Atopic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Yao, C; Ye, W | 1 |
| Cho, I; Cho, YY; Kang, HC; Kim, KB; Kwack, SJ; Lee, HS; Lee, JK; Lee, JY; Seok, JK; Yang, G | 1 |
2 other study(ies) available for celastrol and Dermatitis, Atopic
| Article | Year |
|---|---|
Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2.
Topics: Animals; Cell Degranulation; Dermatitis, Atopic; Dinitrofluorobenzene; Mast Cells; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2023 |
Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells.
Topics: Allergens; Animals; Cell Line, Tumor; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Immunity, Innate; Inflammation; Keratinocytes; Lymphocytes; Mice; NF-kappa B; Pentacyclic Triterpenes; Pyroglyphidae; Skin; Thymic Stromal Lymphopoietin | 2021 |